Stanislas Roux-Vaillard

Stanislas Roux-Vaillard

Partner
Paris

Email [email protected]​hoganlovells.com

Phone +33 1 53 67 18 87

Fax +33 1 53 67 47 48

LanguagesEnglish, French, German

Practice groupIntellectual Property, Media, and Technology

Feted as the 'most talented lawyer of his generation in France'

Managing Intellectual Property 2015

As the partner leading the IPMT team in the Hogan Lovells Paris office, Stanislas Roux-Vaillard is an experienced patent litigator mainly involved in national and multi-jurisdictional patent litigations, mediations and arbitrations, representing international clients, notably in the field of life sciences and telecommunications. Stan brings insight to clients willing to take advantage of French patent law. Admitted to the Paris Bar, he represents clients by advocating in IP French courts, on first instance and on appeal.

With a network of talented patent litigators worldwide, Stan also takes part in the conception and execution of the multijurisdictional strategies of clients, along the specifics of their industry and business model. He is involved in a number of pharma and biotech cases helping clients make the most of their patent exclusivity. He and his team collected the highest award for patent infringement in France and in Europe. He represents clients in the telecom industry in contractual defences to standard essential patents and in non-essential patent claims brought by non-practicing entities.

In specific chemistry and mechanical engineering cases, his ability to use evidence gathering tools such as the saisie-contrefaçon helped clients gain leverage for early settlement of infringement situations. Stan is also involved in patent portfolio and know-how review and licensing, notably in corporate deals where IP valuation is key. He regularly writes articles on intellectual property developments in France. Stan is the author of the 'France' chapter of The Intellectual Property Law Review, Law Business Research Ltd and is a research partner of the ABA Section of International Law.

Awards and recognitions

2021

Intellectual Property: Patents (France)
Chambers Global

2018-2020

Healthcare and life sciences (France), Recommended
Legal 500 EMEA

2018-2019

Intellectual Property: Patents, Next Generation
Legal 500 EMEA

2018-2020

Intellectual Property (France)
Chambers Global

2020

Recommended as a Global Leader in Life Sciences - Patent Litigation
Who's Who Legal

2020

Recommended as a Global Leader in Patents
Who's Who Legal

2020

Recommended as a National Leader in Life Sciences
Who's Who Legal

2020

Recommended as a National Leader in Patents
Who's Who Legal

Education and admissions

Education

Doctorat, Université Paris II Panthéon-Assas, 2001

LL.M., John Marshall Law School - Chicago, 2000

Memberships

International Association for the Protection of Intellectual Property ("AIPPI")

Association des Praticiens Européens des Brevets ("APEB")

European Patent Lawyers Association ("EPLAW")

Association Française des Praticiens du Droit des Marques et des Modèles ("APRAM")

Bar admissions and qualifications

Paris

Representative experience

Representing a US pharma company to enforce its patent rights on an oncology combination and collecting €28m.

Represented a French pharma company in defending a €1.5m claim initiated by a competitor post preliminary injunction proceedings.

Representing a global leader for CAD software in a trade secrets misappropriation case and collecting €5.7 on appeal.

Assisted and represented a Taiwanese smartphone manufacturer in defending its freedom to operate against essential/non-essential patent infringement claims brought by a competitor.

Assisting a chemical company in a mediation to settle an ownership dispute regarding results of a co-development project on microwave activation of HDPE.

Assisting a French energy leader in acquiring a 6000+ patents portfolio as part of the acquisition of a nuclear power leader in a €2.7bn deal.

Assisting a French energy leader in acquiring a 6000+ patents portfolio as part of the acquisition of a nuclear power leader in a €2.7bn deal.

Loading data